ASCO: Gene-Targeted Drug Shows Efficacy for Child, Adult Cancers
Larotrectinib targets tropomyosin receptor kinase fusion proteins
ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
PERFI Feasible for In Vivo Imaging of Nonmelanoma Skin Cancer
Methylene blue infused into peritumoral space, and preferentially retained in tumor
Substantial Increase in Costs With Metastases in Prostate CA
Costs peak during month of metastases diagnosis, reaching $13,291
Cool Water Works As Well As Hot for Ridding Hands of Germs
Time spent scrubbing hands with soap more important that water temperature
May 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2017. This roundup includes...
Concerns Limit Hospice Use for Hematologic Oncologists
Almost half of respondents felt that home hospice was inadequate for their patients' needs
Certain Breast CA Patients Benefit From Adjuvant Capecitabine
Capecitabine cut risk of relapse, death by 30 percent over five years, researchers say
High Costs for Myeloma Patients Not Getting Low-Income Subsidy
For those aged 75 to 84 years, LIS receipt linked to increased odds of receiving immunomodulatory drugs
Restarting Anticoagulation in Certain VTE Cases Cost-Effective
Treating patients with predicted VTE risk of 17.5 percent or more may be cost-effective
